In sum, the method described here with three elements of surveillance data: age, MCV vaccination status and IgM results, which are generally readily available and continuously updated, provide the national or sub-national level program manager another tool to identify areas with low measles coverage and implement appropriate response measures and evaluate progress. The gene discussed is CD40LG; the disease is measles.